Mendelian randomization identifies FLCN expression as a mediator of diabetic retinopathy Read more about Mendelian randomization identifies FLCN expression as a mediator of diabetic retinopathy
Circulating tumor DNA genomics reveal potential mechanisms of resistance to BRAF-targeted therapies in patients with BRAF-mutant metastatic non–small cell lung cancer Read more about Circulating tumor DNA genomics reveal potential mechanisms of resistance to BRAF-targeted therapies in patients with BRAF-mutant metastatic non–small cell lung cancer
Real-world PD-L1 test utilization and analytical concordance of the PD-L1 IHC 28-8 and 22C3 assays in patients with breast cancer Read more about Real-world PD-L1 test utilization and analytical concordance of the PD-L1 IHC 28-8 and 22C3 assays in patients with breast cancer
Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC) Read more about Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)
NTRK Fusions and Trk Proteins: What are They and How to Test for Them Read more about NTRK Fusions and Trk Proteins: What are They and How to Test for Them
A solid variant of splenic mesothelial cyst, a case report with molecular analysis Read more about A solid variant of splenic mesothelial cyst, a case report with molecular analysis
Radiogenomic analysis of locally advanced lung cancer based on CT imaging and intratreatment changes in cell-free DNA Read more about Radiogenomic analysis of locally advanced lung cancer based on CT imaging and intratreatment changes in cell-free DNA
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma Read more about Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma
EZH2 expression is associated with inferior overall survival in mantle cell lymphoma Read more about EZH2 expression is associated with inferior overall survival in mantle cell lymphoma
Aligning Tumor Mutational Burden (TMB) quantification across diagnostic platforms Read more about Aligning Tumor Mutational Burden (TMB) quantification across diagnostic platforms